ERE
0.015
50%
ENV
0.002
-33.3%
D3E
0.385
24.2%
GLL
0.005
-28.6%
DUB
0.011
22.2%
FBR
0.003
-25%
SOP
0.044
22.2%
OCT
0.019
-24%
HWK
0.03
20%
BSR
0.28
-22.2%
GNM
0.037
19.4%
AM3
0.004
-20%
TSK
0.1
17.6%
TR8
0.016
-20%
BST
0.36
16.1%
AXQ
5.01
-17.7%
FRX
0.022
15.8%
IPD
0.005
-16.7%
NVU
0.047
14.6%
NRX
0.01
-16.7%
OMX
0.063
14.5%
KCN
3.65
-16.1%
PVT
0.016
14.3%
AAU
0.006
-14.3%
VBS
0.2
14.3%
CLA
0.006
-14.3%
CKA
0.057
14%
OEL
0.006
-14.3%
CPN
0.125
13.6%
PET
0.006
-14.3%
HFR
0.025
13.6%
WRX
0.019
-13.6%
CGR
0.085
13.3%
ADR
0.13
-13.3%
BAS
0.052
13%
EXT
0.007
-12.5%
PR1
0.37
12.1%
IMI
0.007
-12.5%
ZAG
0.037
12.1%
OVT
0.007
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH